Nirsevimab may offer infants stronger protection against severe respiratory syncytial virus than maternal vaccination, ...
A planned U.S.-funded study of a hepatitis B vaccine drew widespread condemnation from researchers. Now the host country says it cannot proceed.
The chair of a federal vaccine advisory panel charted a new course for the committee in a podcast released Thursday, ...
The U.S. is giving $1.6 million to researchers to study how the hepatitis B vaccine affects newborns in Guinea-Bissau. Local ...
In this Sept. 14, 2021, file photo, a syringe is prepared with the Pfizer COVID-19 vaccine at a clinic at the Reading Area Community College in Reading, Pa. Millions of U.S. workers now have a Jan. 4 ...
Pfizer CEO Albert Bourla said that the main thing getting in the way of changing vaccine discussions in the U.S. is the ...
Sweeping changes to U.S. vaccine policy under Health Secretary Robert F. Kennedy Jr. are creating uncertainty across the pharmaceutical sector, dampening investor confidence and raising concerns among ...
Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) jumped 19.7% in the afternoon session after the company ...
Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
Pfizer in December had warned that the next few years would be bumpy, beginning with 2026, due to lower sales of its COVID ...
Valneva withdraws U.S. applications for its chikungunya vaccine Ixchiq after the FDA suspended the license and placed studies ...
U.S. pharmaceutical companies are stepping up their campaign for higher drug prices in Europe, in some cases threatening to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results